AI tool for leukemia diagnosis using blood or marrow samples
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study tests whether an AI (computer system) can help improve leukemia and related blood cancer diagnoses. You may be able to help if your doctor is already evaluating you for a possible blood disorder and your sample is high enough quality for testing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a current suspected blood-related diagnosis (a suspected leukemia or similar condition)
- The suspected diagnosis is the main reason you are being evaluated right now
- You are at least 18 years old
- Your provided sample must pass initial lab quality checks
- Your sample must not be too small, damaged, or degraded to make a standard diagnosis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced DNA sequencing to figure out unclear or unusual blood (hematologic) conditions when standard tests are not enough. It may help your care team reach a more accurate diagnosis by better understanding what’s driving your illness.
This trial tests if an artificial intelligence (AI) program can help people with blood cancer learn about their condition and treatment. The goal is to see if AI-assisted education improves their understanding and care.
This trial tests an AI tool that helps diagnose brain tumors like glioma, brain metastases, and lymphoma using MRI scans. It may allow faster and more accurate diagnosis without needing additional tests.
This trial tests if an AI tool can help you create a personalized list of questions about your cancer treatment to ask your doctor at your next visit. It is for patients with lymphoma or multiple myeloma who get regular infusion therapy.
This study tests an artificial intelligence tool that helps analyze blood test results more accurately. Researchers want to validate how well this AI system works by comparing its analysis to what laboratory professionals determine.
This study tests an artificial intelligence (AI) system that uses your health information and medical images to better judge cancer risk and support diagnosis and treatment decisions. It may help doctors make more consistent assessments by combining clinical records, imaging, and other lab-style data.
Hear when a new Hematologic Malignancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.